Share:
Original Article

Fractional carbon dioxide (CO₂) laser alone versus fractional CO₂ laser combined with triamcinolone acetonide or tricholoroacetic acid in keloid treatment: A comparative clinical & radiological study

Author Affiliation(s)

Abstract

Introduction: Keloids are benign fibro-proliferative scarring extending outside the initial wound. Different modalities of treatment as intralesional corticosteroid injection, fractional CO₂ laser and others can be used either as mono or combined therapies.


Objectives: To assess the role of fractional CO2 laser versus fractional CO2 laser accompanied with either triamcinolone acetonide or trichloroacetic acid 20% in keloid treatment clinically and radiologically.


Methods: The current study was conducted on 45 Egyptian participants with keloid scar at different sites of the body. They were classified into three groups treated by fractional CO2 laser only (group I), fractional CO2 laser followed by triamcinolone acetonide (group II) or trichloroacetic acid application (group III) respectively. Evaluation of the keloid was done with Vancouver Scar Scale (VSS) and Color Doppler Ultrasound (CDU) before and after treatment. Four sessions, one month apart were applied for the patients. They were followed up for 8 weeks after the last session.


Results: After treatment, there was high statistically significant reduction in Vancouver Scar Scale among the three groups (P value ≤ 0.001), reduction was more in group II then I then III. Also, high statistically significant reduction in keloid scar thickness assessed by Doppler was recorded (P value ≤0.001 in group II and P value ≤0.01 in group I & III).


Conclusions: Combined therapy is favorable in treatment of keloids. Trichloroacetic acid is a promising modality in treating keloid; hence it can be tried in different combinations. Color Doppler Ultrasound is a promising method of keloids pre- and post-treatment assessment.

Keywords : keloid, fractional carbon dioxide laser, corticosteroids, trichloroacetic acid, Doppler.

References

REFERENCES: 1. Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models. Front Cell Dev Biol. 2020; 8:360. Published 2020 May 26. doi:10.3389/fcell.2020.00360. 2. Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment. Matrix Biol. 2016; 51:37-46. doi:10.1016/j.matbio.2016.01.013. 3. Betarbet U, Blalock TW. Keloids: A Review of Etiology, Prevention, and Treatment. J Clin Aesthet Dermatol. 2020; 13(2):33-43. PMID: 32308783; PMCID: PMC7158916. 4. Thornton NJ, Garcia BA, Hoyer P, Wilkerson MG. Keloid Scars: An Updated Review of Combination Therapies. Cureus. 2021; 13(1):e12999. Published 2021 Jan 30. doi:10.7759/cureus.12999. 5. Cavalié M, Sillard L, Montaudié H, Bahadoran P, Lacour JP, Passeron T. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015; 28(2):74-78. doi:10.1111/dth.12187. 6. Bloom BS, Brauer JA, Geronemus RG. Ablative fractional resurfacing in topical drug delivery: an update and outlook. Dermatol Surg. 2013; 39(6):839-848. doi:10.1111/dsu.12111. 7. Yildirim S, Gurel MS, Gungor S, Tekeli O, Canat D. Comparison of efficacy of chemical peeling with 25% trichloroacetic acid and 0.1% retinoic acid for facial rejuvenation. Postepy Dermatol Alergol. 2016; 33(3):199-205. doi:10.5114/ada.2016.60612. 8. Mari W, Alsabri SG, Tabal N, Younes S, Sherif A, Simman R. Novel Insights on Understanding of Keloid Scar: Article Review. J Am Coll Clin Wound Spec. 2016; 7(1-3):1-7. Published 2016 Nov 30. doi:10.1016/j.jccw.2016.10.001. 9. Shaheen A. Comprehensive Review of Keloid Formation. Clin Res Dermatol. 2017; Open Access 4, 5: 1-18; doi: http://dx.doi.org/10.15226/2378-1726/4/5/00168. 10. Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatol Surg. 2017; 43 Suppl 1:S3-S18. doi:10.1097/DSS.0000000000000819. 11. Maghrabi, Ibrahim A, and Ahmed M Kabel. Management of Keloids and Hypertrophic Scars: Role of Nutrition, Drugs, Cryotherapy and Phototherapy." World Journal of Nutrition and Health 2.2, 2014: 28-32; doi: 10.12691/jnh-2-2-4 12. Behera B, Kumari R, Thappa DM, Malathi M. Therapeutic Efficacy of Intralesional Steroid With Carbon Dioxide Laser Versus With Cryotherapy in Treatment of Keloids: A Randomized Controlled Trial. Dermatol Surg. 2016; 42(10):1188-1198. doi:10.1097/DSS.0000000000000873. 13. Azzam OA, Bassiouny DA, El-Hawary MS, El Maadawi ZM, Sobhi RM, El-Mesidy MS. Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study. Lasers Med Sci. 2016; 31(1):9-18. doi:10.1007/s10103-015-1824-4. 14. Omi T, Numano K. The Role of the CO2 Laser and Fractional CO2 Laser in Dermatology. Laser Ther. 2014; 23(1):49-60. doi:10.5978/islsm.14-RE-01. 15. Srivastava S, Kumari H, Singh A. Comparison of Fractional CO2 Laser, Verapamil, and Triamcinolone for the Treatment of Keloid. Adv Wound Care (New Rochelle). 2019; 8(1):7-13. doi:10.1089/wound.2018.0798. 16. Al Janahi S, Lee M, Lam C, Chung HJ. Laser-assisted drug delivery in the treatment of keloids: A case of extensive refractory keloids successfully treated with fractional carbon dioxide laser followed by topical application and intralesional injection of steroid suspension. JAAD Case Rep. 2019; 5(10):840-843. Published 2019 Sep 24. doi:10.1016/j.jdcr.2019.07.010. 17. Alegre-Sánchez A, Jiménez-Gómez N, Boixeda P. Laser-Assisted Drug Delivery. Vehiculización de fármacos asistida por láser. Actas Dermosifiliogr (Engl Ed). 2018; 109(10):858-867. doi:10.1016/j.ad.2018.07.008. 18. Annabathula A, Sekar CS, Srinivas CR. Fractional Carbon Dioxide, Long Pulse Nd:YAG and Pulsed Dye Laser in the Management of Keloids. J Cutan Aesthet Surg. 2017; 10(2):76-80. doi:10.4103/JCAS.JCAS_136_16. 19. Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013; 45(3):135-140. doi:10.1002/lsm.22120. 20. Alexander S, Girisha BS, Sripathi H, Noronha TM, Alva AC. Efficacy of fractional CO2 laser with intralesional steroid compared with intralesional steroid alone in the treatment of keloids and hypertrophic scars. J Cosmet Dermatol. 2019; 18(6):1648-1656. doi:10.1111/jocd.12887. 21. Ghonaim N. Comparative study of the 80% trichloroacetic acid multiple puncture technique versus botulinum toxin type A in the treatment of keloid scars. Egypt J Dermatol Venerol 2013, 33:22-7; doi: 10.7123/01.EJDV.0000431207.04926.59. 22. Heppt MV, Breuninger H, Reinholz M, Feller-Heppt G, Ruzicka T, Gauglitz GG. Current Strategies in the Treatment of Scars and Keloids. Facial Plast Surg. 2015; 31(4):386-395. doi:10.1055/s-0035-1563694. 23. Elrefaie AM, Salem RM, Faheem MH. High-resolution ultrasound for keloids and hypertrophic scar assessment. Lasers Med Sci. 2020; 35(2):379-385. doi:10.1007/s10103-019-02830-4. 24. Lobos N, Wortsman X, Valenzuela F, Alonso F. Color Doppler Ultrasound Assessment of Activity in Keloids. Dermatol Surg. 2017; 43(6):817-825. doi:10.1097/DSS.0000000000001052.

Send mail to Author


Send Cancel